Document:

EX-10.1

 Exhibit 10.1 

PROMISSORY NOTE 
  

			
	 $1,000,000
	  	As of August 10, 2021

 TZP Strategies Acquisition Corp. (“Maker”) promises to pay to the order of TZPS SPAC Holdings
LLC or its successors or assigns (“Payee”) the principal sum of One Million Dollars and No Cents ($1,000,000) in lawful money of the United States of America, on the terms and conditions described below. 

1. Principal. The principal balance of this Note shall be repayable on the consummation of the Maker’s initial merger, stock
exchange, asset acquisition, stock purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities (a “Business Combination”). Payee understands that if a Business Combination is
not consummated, this Note will not be repaid and all amounts owed hereunder will be forgiven except to the extent that the Maker has funds available to it outside of its trust account established in connection with its initial public offering. 

2. Interest. No interest shall accrue on the unpaid principal balance of this Note. 

3. Application of Payments. All payments shall be applied first to payment in full of any costs incurred in the collection of any sum
due under this Note, including (without limitation) reasonable attorneys’ fees, then to the payment in full of any late charges and finally to the reduction of the unpaid principal balance of this Note. 

4. Events of Default. The following shall constitute Events of Default: 

(a) Failure to Make Required Payments. Failure by Maker to pay the principal of this Note within five (5) business days following
the date when due. 
 (b) Voluntary Bankruptcy, Etc. The commencement by Maker of a voluntary case under the Federal Bankruptcy Code,
as now constituted or hereafter amended, or any other applicable federal or state bankruptcy, insolvency, reorganization, rehabilitation or other similar law, or the consent by it to the appointment of or taking possession by a receiver, liquidator,
assignee, trustee, custodian, sequestrator (or other similar official) of Maker or for any substantial part of its property, or the making by it of any assignment for the benefit of creditors, or the failure of Maker generally to pay its debts as
such debts become due, or the taking of corporate action by Maker in furtherance of any of the foregoing. 
 (c) Involuntary Bankruptcy,
Etc. The entry of a decree or order for relief by a court having jurisdiction in the premises in respect of maker in an involuntary case under the Federal Bankruptcy Code, as now or hereafter constituted, or any other applicable federal or state
bankruptcy, insolvency or other similar law, or appointing a receiver, liquidator, assignee, custodian, trustee, sequestrator (or similar official) of Maker or for any substantial part of its property, or ordering the
winding-up or liquidation of its affairs, and the continuance of any such decree or order unstayed and in effect for a period of 60 consecutive days. 

 5. Remedies. 

(a) Upon the occurrence of an Event of Default specified in Section 4(a), Payee may, by written notice to Maker, declare this Note to be
due and payable, whereupon the principal amount of this Note, and all other amounts payable thereunder, shall become immediately due and payable without presentment, demand, protest or other notice of any kind, all of which are hereby expressly
waived, anything contained herein or in the documents evidencing the same to the contrary notwithstanding. 
 (b) Upon the occurrence of an
Event of Default specified in Sections 4(b) and 4(c), the unpaid principal balance of, and all other sums payable with regard to, this Note shall automatically and immediately become due and payable, in all cases without any action on the part of
Payee. 
 6. Conversion. Upon consummation of a Business Combination, the Payee shall have the option, but not the obligation, to
convert the principal balance of this Note, in whole or in part at the option of the Payee, into Private Placement Warrants (as defined in that certain Warrant Agreement, dated January 19, 2021, by and between the Maker and Continental Stock
Transfer & Trust Company), at a price of $1.50 per Private Placement Warrant. As promptly after notice by Payee to Maker to convert the principal balance of this Note, which must be made at least 24 hours prior to the consummation of the
Business Combination, as reasonably practicable and after Payee’s surrender of this Note, Maker shall have issued and delivered to Payee, without any charge to Payee, a warrant certificate or certificates (issued in the name(s) requested by
Payee), or made appropriate book-entry notation on the books and records of the Maker, for the number of Warrants of Maker issuable upon the conversion of this Note. 

7. Waivers. Maker and all endorsers and guarantors of, and sureties for, this Note waive presentment for payment, demand, notice of
dishonor, protest, and notice of protest with regard to the Note, all errors, defects and imperfections in any proceedings instituted by Payee under the terms of this Note, and all benefits that might accrue to Maker by virtue of any present or
future laws exempting any property, real or personal, or any part of the proceeds arising from any sale of any such property, from attachment, levy or sale under execution, or providing for any stay of execution, exemption from civil process, or
extension of time for payment; and Maker agrees that any real estate that may be levied upon pursuant to a judgment obtained by virtue hereof, on any writ of execution issued hereon, may be sold upon any such writ in whole or in part in any order
desired by Payee. 
 8. Unconditional Liability. Maker hereby waives all notices in connection with the delivery, acceptance,
performance, default, or enforcement of the payment of this Note, and agrees that its liability shall be unconditional, without regard to the liability of any other party, and shall not be affected in any manner by any indulgence, extension of time,
renewal, waiver or modification granted or consented to by Payee, and consents to any and all extensions of time, renewals, waivers, or modifications that may be granted by Payee with respect to the payment or other provisions of this Note, and
agree that additional makers, endorsers, guarantors, or sureties may become parties hereto without notice to them or affecting their liability hereunder. 

  
 2 

 9. Notices. Any notice called for hereunder shall be deemed properly given if
(i) sent by certified mail, return receipt requested, (ii) personally delivered, (iii) dispatched by any form of private or governmental express mail or delivery service providing receipted delivery, (iv) sent by telefacsimile or
(v) sent by e-mail, to the following addresses or to such other address as either party may designate by notice in accordance with this Section: 

If to Maker: 
 7 Times Square,
Suite 4307 
 New York, New York 10036 

(212) 398-0300 

If to Payee: 
 7 Times Square,
Suite 4307 
 New York, New York 10036 

(212) 398-0300 

Notice shall be deemed given on the earlier of (i) actual receipt by the receiving party, (ii) the date shown on a telefacsimile transmission
confirmation, (iii) the date on which an e-mail transmission was received by the receiving party’s on-line access provider (iv) the date reflected on a
signed delivery receipt, or (vi) two (2) Business Days following tender of delivery or dispatch by express mail or delivery service. 

10. Trust Waiver. Notwithstanding anything herein to the contrary, the Payee hereby waives any and all right, title, interest or claim
of any kind (“Claim”) in or to any distribution of or from the trust account established in which proceeds of the Makers initial public offering of securities (“IPO”) (including the deferred underwriters discounts
and commissions) and proceeds of the sale of the warrants issued in a private placement which occurred in connection with the consummation of the IPO are deposited, as described in greater detail in the registration statement and prospectus filed
with the Securities and Exchange Commission in connection with the IPO, and hereby agrees not to seek recourse, reimbursement, payment or satisfaction for any Claim against the trust account for any reason whatsoever. 

11. Construction. This Note shall be construed and enforced in accordance with the domestic, internal law, but not the law of conflict
of laws, of the State of New York. 
 12. Severability. Any provision contained in this Note which is prohibited or unenforceable in
any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof, and any such prohibition or unenforceability in any jurisdiction shall not
invalidate or render unenforceable such provision in any other jurisdiction. 
 [Remainder of Page Intentionally Left Blank] 

  
 3 

 IN WITNESS WHEREOF, Maker, intending to be legally bound hereby, has caused this Note to be
duly executed the day and year first above written. 
  

			
	TZP Strategies Acquisition Corp.
		
	By:	 	 /s/ Samuel Katz

		 	Name: Samuel Katz
		 	Title: Chief Executive Officer

  

			
	Agreed and Acknowledged:
	
	TZPS SPAC Holdings LLC,
	a Cayman Islands limited liability company
		
	By:	 	 /s/ Samuel Katz

		 	Name: Samuel Katz
		 	Title: Authorized Signatory

 [Signature Page to Promissory Note]Exhibit
10.64

 

NEITHER
THIS Note nor the securities into which this note is convertible haVE been registered under the securities act of 1933, as amended (the
“act”), or under any state securities law AND NEITHER THIS NOTE NOR ANY INTEREST THEREIN NOR THE SECURITIES INTO WHICH THIS
NOTE IS CONVERTIBLE may be offered, sold, transferred, pledged or otherwise DISPOSED OF EXCEPT PURSUANT TO an effective Registration
Statement under such act and such laws or an exemption from registration under such act and such laws which, in the opinion of counsel
satisfactory to the Company, is available.

 

CELL
SOURCE, INC.

 

Third
Amended and Restated 

 

10.0%
Convertible Note

 

Maturity
Date:October 31, 2021

 

Principal
Amount:$6,000,000

 

This
Third Amended and Restated Convertible Note (the “Note”) is issued by Cell Source, Inc., a Nevada corporation (the “Company”),
effective as of the 18th day of June, 2021 (the “Issuance Date”), to Darlene D. Soave (the “Lender”)
pursuant to the exemptions from registration under the Securities Act of 1933, as amended, and amends and restates the 8% Convertible
Note issued by the Company to the Lender effective as of October 28, 2019, as amended by the Amended and Restated 8% Convertible Note
dated June 18, 2020 and effective as of October 28, 2019, as amended by Amendment No. 1 thereto dated as of December 3, 2020, and as
amended by the Amended and Restated Note dated March 2, 2021 (collectively, the “Original Note”).

 

ARTICLE
I

PAYMENTS OF PRINCIPAL AND INTEREST; EVENTS F DEFAULT

 

For
value received, the Company promises to pay to Lender, or her registered assigns, the lesser of (a) Six Million Dollars ($6,000,000)
or (b) the actual amount advanced to the Company by the Lender (the “Principal Amount”) pursuant to the terms, conditions
and provisions of this Note. The Company shall pay interest to the Lender on the outstanding Principal Amount of this Note in accordance
with Section 1.2 below and such interest shall accrue on each advance of funds from the Lender (each an “Advance”) from the
date of such Advance. Schedule A hereto sets forth a list of all advances made prior to the date hereof. To the extent that any of such
advances are represented by previously issued promissory notes, they will hereafter be governed by this Note.

 

The
Company hereby expressly authorizes the Holder to record on Schedule A hereto the amount and date of each loan made hereunder after the
date hereof and the date and amount of each payment of principal thereon. All such notations shall be presumptive as to the correctness
thereof and the aggregate unpaid amount of loans set forth on such schedule shall be presumed to be the unpaid Principal Amount hereof,
so long as the Holder has delivered to Company a copy of the schedule each time a new notation was made thereon.

 

    	 

     

    

 

Section
1.1 Interest shall accrue daily from the date of each Advance at a rate equal to ten percent (10%) per annum and shall be
payable, at the Company’s option, either in cash or as payment-in-kind in shares of the Company’s Common Stock, on the
Maturity Date. If the Company elects to pay interest in shares of the Company’s Common Stock, the number of shares issuable
shall be determined by diving the dollar value of the interest being paid by $0.75 (as such amount shall be equitably adjusted to
give effect to stock splits, stock dividends and similar transactions).

 

Section
1.2 All payments of principal and interest shall be made to the Lender at the address set forth in Section 3.1or such other
address as the Lender shall notify the Company in writing ten (10) days prior to the due date of any payment or upon any prepayment
of this Note as provided herein.

 

Section
1.3 The occurrence of any of the following events of default ( each an “Event of Default”) shall, at the option of the
Lender, make all sums of principal and interest then remaining unpaid hereon and all other amounts payable hereunder immediately due
and payable, upon demand, without presentment:

 

(a)
the Company fails to pay the Principal Amount and all accrued and unpaid interest on or before the Maturity Date.

 

(b)
the Company breaches any other provision of this Note and such breach is not cured within twenty (20) days after written notice thereof
to the Company.

 

(c)
bankruptcy or insolvency proceedings or other proceedings or relief under any bankruptcy law or any other law, or the issuance of any
notice in relation to such event, for the relief of debtors shall be instituted by the Company.

 

ARTICLE
II

CONVERSION
RIGHTS; CONVERSION PRICE

 

Section
2.1 Conversion. The Company may elect to convert this Note into a number of fully paid and non-assessable shares of the
Company’s Series B Convertible Preferred Stock (the “Series B Stock”) at a conversion price (the “Conversion
Price”) equal to $7.50 per share at any time after the creation of the Series B Stock and before the Maturity Date. If the Company
elects to convert this Note into Series B Stock pursuant to this Section 2.1, the Company shall deliver a notice of such conversion to
the Lender. Upon receipt of such notice, the Lender shall promptly deliver this Note to the Company for cancellation and the Company
shall issue and deliver to Lender the applicable number of shares of Series B Stock.

 

Section
2.2 Warrant. For each $500,000 of Advances provided by Lender under this Note, the Company shall issue to Lender a
warrant to purchase 400,000 shares of the Company’s Common Stock at an exercise price of $1.25 per share. Each warrant will
have a five (5) year term. The Lender hereby acknowledges the receipt of warrants to purchase 2,800,000 shares of Common Stock that
have been issued prior to the date of this Note.

 

    	2

     

    

 

Section
2.3 Notice of Corporate Action. If at any time:

 

(a) the
Company shall take a record of the holders of its Common Stock or Series B stock for the purpose of entitling them to receive a dividend
or other distribution, or any right to subscribe or purchase any evidences of indebtedness, any shares of stock of any class or any other
securities or property, or to receive any other right, or

 

(b) there
shall be any capital reorganization of the Company, any reclassification or recapitalization of the capital stock of the Company or any
consolidation or merger of the Company with, or any sale, transfer or other disposition of all or substantially all of the property,
assets or business of the Company to, another corporation or,

 

(c) there
shall a voluntary or involuntary dissolution, liquidation or winding up of the Company; then, in any one or more of such cases, the Company
shall give to Lender (i) at least 10 days’ prior written notice of the date on which a record date shall be selected for such dividend,
distribution or right or for determining rights to vote in respect of any such reorganization, reclassification, merger, consolidation,
sale, transfer, disposition, liquidation or winding up, and (ii) in the case of any such reorganization, reclassification, merger, consolidation,
sale, transfer, disposition, dissolution, liquidation or winding up, at least 10 days’ prior written notice of the date when the
same shall take place. Such notice in accordance with the foregoing clause also shall specify (x) the date on which any such record is
to be taken for the purpose of such dividend, distribution or right, the date on which the holders of Common Stock or Series B Stock
shall be entitled to any such dividend, distribution or right, and the amount and character thereof, and (y) the date on which any such
reorganization, reclassification, merger, consolidation, sale, transfer, disposition, dissolution, liquidation or winding up is to take
place and the time, if any such time is to be fixed, as of which the holders of Common Stock or Series B Stock shall be entitled to exchange
their shares of Common Stock or series B Stock for securities or other property deliverable upon such disposition, dissolution, liquidation
or winding up. Each such written notice shall be sufficiently given if addressed to Lender at the last address of Lender appearing on
the books of the Company and delivered in accordance with Section 4.1.

 

Section
2.4 Restrictions on Securities. This Note has been issued by the Company pursuant to the exemption from registration
under the Securities Act of 1933, as amended (the “Act”). None of this Note or the shares of Series B Stock issuable
upon conversion of this Note may be offered, sold or otherwise transferred unless (i) they first shall have been registered under
the Act and applicable state securities laws or (ii) the Company shall have been furnished with an opinion of legal counsel (in
form, substance and scope reasonably acceptable to Company) to the effect that such sale or transfer is exempt from the registration
requirements of the Act. Each certificate for shares of Series B Stock issuable upon conversion of this Note that have not been so
registered and that have not been sold pursuant to an exemption that permits removal of the applicable legend, shall bear a legend
substantially in the following form, as appropriate.

 

the
securities represented hereby have not been registered under the Securities Act of 1933, as amended (the “Act”). the securities
represented hereby may not be offered, sold or otherwise transferred unless they are registered under the act and applicable state securities
laws, or such offers, sales and transfers are made pursuant to an available exemption from the registration requirements of those laws.

 

    	3

     

    

 

Upon
the request of a holder of a certificate representing any shares of Series B Stock issuable upon conversion of this Note, the Company
shall remove the foregoing legend from the certificate or issue to such Lender a new certificate free of any transfer legend, if (a)
with such request, the Company shall have received an opinion of counsel, reasonably satisfactory to the Company in form, substance and
scope, to the effect that any such legend may be removed from such certificate or (b) a registration statement under the Act covering
such securities is in effect.

 

ARTICLE
III

MISCELLANEOUS

 

Section
3.1 Notices. Any notice herein required or permitted to be given shall be in writing and may be personally served or
delivered by courier or sent by United States mail and shall be deemed to have been given upon receipt if personally served (which
shall include telephone line facsimile transmission) or sent by courier or three (3) days after being deposited in the United States
mail, certified, with postage pre-paid and properly addressed, if sent by mail. For the purposes hereof, the address of the Lender
shall be 341 Lakewood Drive, Bloomfield Hills, Michigan 48304; and the address of the Company shall be 57 West 57th
Street, Suite 400, New York, New York 10019. The Company shall accept electronic notice at “ishimrat@cell-source.com”.
Both the Lender and the Company may change the address for service by delivery of written notice to the other as herein
provided.

 

Section
3.2 Entire Agreement and Amendment Provision. This Note represents the entire agreement between the parties hereto with
respect to the subject matter hereof and there are no representations, warranties or commitments, except as set forth herein, and replaces
and is issued in substitution for the Original Note, which is hereby cancelled. This Note and any provision hereof may be amended only
by an instrument in writing signed by the Company and the Lender.

 

Section
3.3 Assignability. This Note shall be binding upon the Company and its successors and assigns and shall inure to the
benefit of the Lender and its successors and assigns; provided, however, that so long as no Event of Default has occurred, this Note
shall only be transferable in whole subject to the restrictions contained in the restrictive legend on the first page of this
Note.

 

Section
3.4 Governing Law. This Note shall be governed by the internal laws of the State of New York, without regard to conflicts of
laws principles. The parties hereby submit to the exclusive jurisdiction and venue of the state or federal courts sited in the State
of New Jersey with respect to any dispute arising under this Note.

 

Section
3.5 Replacement of Note. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory to
it of the loss, theft, destruction or mutilation of this Note, and in case of loss, theft or destruction, of indemnity or security reasonably
satisfactory to it (which shall not include the posting of any bond), and upon surrender and cancellation of such Note, if mutilated,
the Company will make and deliver a new Note of like tenor.

 

    	4

     

    

 

Section
3.6 This Note shall not entitle the Lender to any of the rights of a stockholder of the Company, including without limitation,
the right to vote, to receive dividends and other distributions, or to receive any notice of, or to attend, meetings of stockholders
or any other proceedings of the Company, unless and to the extent converted into shares of Series B Stock in accordance with the terms
hereof.

 

Section
3.7 Severability. In case any provision of this Note is held by a court of competent jurisdiction to be excessive in
scope or otherwise invalid or unenforceable, such provision shall be adjusted rather than voided, if possible, so that it is
enforceable to the maximum extent possible, and the validity and enforceability of the remaining provisions of this Note will not in
any way be affected or impaired thereby.

 

Section
3.8 Headings. The headings of the sections of this Note are inserted for convenience only and do not affect the meaning
of such section.

 

Section
3.9. Replacement. This Note replaces and supersedes the Original Note in its entirety.

 

Section
3.10 Counterparts. This Note may be executed in multiple counterparts, each of which shall be an original, but all of
this shall be deemed to constitute one instrument.

 

    	5

     

    

 

IN
WITNESS WHEREOF, with the intent to be legally bound hereby, the Company has executed this Amended and Restated Note effective as of
June 18, 2021.

 

 

	 	CELL
    SOURCE, INC.
	 	 
	 	By:	 
	 	Name:	Itamar
    Shimrat
	 	Title:	Chief
    Executive Officer

 

	 	LENDER
	 	 
	 	Darlene
    Soave

 

    	6

     

    

 

Schedule
A

 

Schedule
of Loans and Payments

 

	Date	 	Amount of Loan	 	 	Amount of Principal Paid	 	 	Balance Remaining Unpaid	 	 	Notation Made By	 
	10-08-2019	 	$	500,000	 	 	 	-0-	 	 	$	500,000	 	 	 		 
	03-02-2020	 	$	500,000	 	 	 	-0-	 	 	$	500,000	 	 	 		 
	06-019-2021	 	$	500,000	 	 	 	-0-	 	 	$	500,000	 	 	 		 
	12-03-2021	 	$	500,000	 	 	 	-0-	 	 	$	500,000	 	 	 		 
	03-02-2021	 	$	500,000	 	 	 	-0-	 	 	$	500,000	 	 	 	        	 
	06-18-2021	 	$	1,000,000	 	 	 	-0-	 	 	$	1,000,000	 	 	 		 

 

    	A-I

     

    

 

EXHIBIT 1
 

CONVERSION
NOTICE

 

 

(To
be executed by the Lender in order to Convert the Note)

TO:

 

The
undersigned hereby irrevocably elects to convert US $__________ of the Principal Amount outstanding under the above Note into shares
of Series B Convertible Stock of Cell Source, Inc., according to the conditions stated therein. If shares are to be issued in the name
of a person other than the undersigned, the undersigned will pay all transfer taxes payable with respect thereto and is delivering herewith
such certificates and opinions as reasonably requested by the Company in accordance therewith. No fee will be charged to the Lender for
any conversion, except for such transfer taxes, if any.

 

Conversion
Date:____________________________________________________________________

 

Applicable
Conversion Price: $__________________________________________________________

 

Signature:________________________________________________________

 

Name:________________________________________________________

 

Address:________________________________________________________

 

                ________________________________________________________ 

 

Tax
I.D. or Soc. Sec. No.:________________________________________________________

 

Principal
Amount to be converted: US $___________________________________________________

 

Amount
of Note unconverted: US $_______________________________________________________

 

Number
of shares of Series B Stock to be issued:_____________________________________________

 

    	A-II

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00332-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00332-of-00352.parquet"}]]